Replies to post #45536 on Sigma Labs Inc (SASI)

[alanthill]

From the investors perspective (assuming the collateral is solid) they have a minimum return of 15% on their investment within the year and the potential for significantly higher returns if sales develop as hoped for. That's not bad either.

[El_Jefe42]

Thanks for your insight. All sounds reasonable. I've asked and I think they owe us a status of the S-1. The SEC should have sent comments long ago. I suppose these investors are satisfied with the current state of the S-1, and by inference we are expected to be as well.

I am just now able to read the filing Alan, and I agree with you. This is a pretty good finance transaction that limits the damage to everyone, common shareholders included. At first read I don't see anything that looks like lending shenanigans. In fact just the opposite. No new class of shares has been established. No ability to leverage the convertible position is in place for the lenders. No back dated price kickers are in place for valuing the notes and associated conversion. None of that toxic crap is part of this.
I am of the opinion that the requirement to maintain the trading ability on the OTC is a safety outlet for the two investors if things turn south in the economy as a whole. But what does stand out to me, is that the two investors appear to be expecting that indeed SGLB has a high probability of realizing nice gains with what they can see. It looks to me like there is a path to up-listing, the secondary offering, and an anticipated higher valuation on the NASDAQ.
I sure would like to know who the accredited investors are. But we will likely never find out.
It looks to me like the 'behind the curtain' view must be promising.

All the best,
Silversmith